Multidrug resistance profile and SCCmec typing of Staphylococcus haemolyticus in commensal and clinical isolates

Long regarded as a contaminant in clinical cultures, Staphylococcus haemolyticus has emerged as a major bacterial species responsible for a variety of serious human infections. This species is increasingly prevalent as an opportunistic agent, and the evolution of S. haemolyticus as a multiple drug-r...

Full description

Bibliographic Details
Published in:Journal of Applied Pharmaceutical Science
Main Author: Azharollah F.H.; Ahmadunissah A.; Abdullah M.F.F.; Nawi S.F.A.M.; Abdul-Aziz A.
Format: Article
Language:English
Published: Open Science Publishers LLP Inc. 2023
Online Access:https://www.scopus.com/inward/record.uri?eid=2-s2.0-85152074285&doi=10.7324%2fJAPS.2023.73319&partnerID=40&md5=676189f70d6c06f7b5912a3621d50628
id 2-s2.0-85152074285
spelling 2-s2.0-85152074285
Azharollah F.H.; Ahmadunissah A.; Abdullah M.F.F.; Nawi S.F.A.M.; Abdul-Aziz A.
Multidrug resistance profile and SCCmec typing of Staphylococcus haemolyticus in commensal and clinical isolates
2023
Journal of Applied Pharmaceutical Science
13
3
10.7324/JAPS.2023.73319
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85152074285&doi=10.7324%2fJAPS.2023.73319&partnerID=40&md5=676189f70d6c06f7b5912a3621d50628
Long regarded as a contaminant in clinical cultures, Staphylococcus haemolyticus has emerged as a major bacterial species responsible for a variety of serious human infections. This species is increasingly prevalent as an opportunistic agent, and the evolution of S. haemolyticus as a multiple drug-resistant strain is emerging as a major threat in worldwide healthcare facilities. In this study, 50 commensal and 98 clinical strains of S. haemolyticus were isolated and confirmed via superoxide dismutase gene sequence analysis. All isolates were tested against a series of antibiotics from ten different classes and screened for Staphylococcus Chromosomal Cassette (SCC) Types I, II, III, IV, and V. Staphylococcus haemolyticus resistance to antibiotics was observed in both the clinical and commensal strains isolated from healthy adults. In clinical isolates, the highest resistance was observed against erythromycin at 79.6% followed by cefoxitin (71.4%), while a high percentage of the commensals were resistant against cefoxitin (56.0%) and tigecycline (40.0%). More than half of the S. haemolyticus clinical isolates are multidrug resistance (MDR) strains at 54.1%, while 20.0% of the S. haemolyticus commensals are MDR strains. The majority of these MDR strains are methicillin-resistant S. haemolyticus (MRSH) suggesting a close relationship between the methicillin-resistant strains and resistance to multiple classes of antibiotics. SCCmec Type II is the most abundant type observed in both commensal (92.0%) and clinical (99.0%) isolates of S. haemolyticus followed by Type V at 38.0% and 46.9%, respectively. The similar pattern of typing observed indicates the possibility that the clinical isolates of S. haemolyticus could have originated from the commensal strains that had successfully entered the host and caused infections. The antibiotic profile indicates the natural resistance of S. haemolyticus to antibiotics, even among the commensal strains. It also appears that transmission of genetic determinants for antibiotic resistance is common and widespread among all the S. haemolyticus isolates. Commensal strains of S. haemolyticus may thus serve as reservoirs for the transmission of antibiotic resistance and the development of opportunistic strains © 2023 Farhan Haziq Azharollah et al. This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/)
Open Science Publishers LLP Inc.
22313354
English
Article
All Open Access; Gold Open Access
author Azharollah F.H.; Ahmadunissah A.; Abdullah M.F.F.; Nawi S.F.A.M.; Abdul-Aziz A.
spellingShingle Azharollah F.H.; Ahmadunissah A.; Abdullah M.F.F.; Nawi S.F.A.M.; Abdul-Aziz A.
Multidrug resistance profile and SCCmec typing of Staphylococcus haemolyticus in commensal and clinical isolates
author_facet Azharollah F.H.; Ahmadunissah A.; Abdullah M.F.F.; Nawi S.F.A.M.; Abdul-Aziz A.
author_sort Azharollah F.H.; Ahmadunissah A.; Abdullah M.F.F.; Nawi S.F.A.M.; Abdul-Aziz A.
title Multidrug resistance profile and SCCmec typing of Staphylococcus haemolyticus in commensal and clinical isolates
title_short Multidrug resistance profile and SCCmec typing of Staphylococcus haemolyticus in commensal and clinical isolates
title_full Multidrug resistance profile and SCCmec typing of Staphylococcus haemolyticus in commensal and clinical isolates
title_fullStr Multidrug resistance profile and SCCmec typing of Staphylococcus haemolyticus in commensal and clinical isolates
title_full_unstemmed Multidrug resistance profile and SCCmec typing of Staphylococcus haemolyticus in commensal and clinical isolates
title_sort Multidrug resistance profile and SCCmec typing of Staphylococcus haemolyticus in commensal and clinical isolates
publishDate 2023
container_title Journal of Applied Pharmaceutical Science
container_volume 13
container_issue 3
doi_str_mv 10.7324/JAPS.2023.73319
url https://www.scopus.com/inward/record.uri?eid=2-s2.0-85152074285&doi=10.7324%2fJAPS.2023.73319&partnerID=40&md5=676189f70d6c06f7b5912a3621d50628
description Long regarded as a contaminant in clinical cultures, Staphylococcus haemolyticus has emerged as a major bacterial species responsible for a variety of serious human infections. This species is increasingly prevalent as an opportunistic agent, and the evolution of S. haemolyticus as a multiple drug-resistant strain is emerging as a major threat in worldwide healthcare facilities. In this study, 50 commensal and 98 clinical strains of S. haemolyticus were isolated and confirmed via superoxide dismutase gene sequence analysis. All isolates were tested against a series of antibiotics from ten different classes and screened for Staphylococcus Chromosomal Cassette (SCC) Types I, II, III, IV, and V. Staphylococcus haemolyticus resistance to antibiotics was observed in both the clinical and commensal strains isolated from healthy adults. In clinical isolates, the highest resistance was observed against erythromycin at 79.6% followed by cefoxitin (71.4%), while a high percentage of the commensals were resistant against cefoxitin (56.0%) and tigecycline (40.0%). More than half of the S. haemolyticus clinical isolates are multidrug resistance (MDR) strains at 54.1%, while 20.0% of the S. haemolyticus commensals are MDR strains. The majority of these MDR strains are methicillin-resistant S. haemolyticus (MRSH) suggesting a close relationship between the methicillin-resistant strains and resistance to multiple classes of antibiotics. SCCmec Type II is the most abundant type observed in both commensal (92.0%) and clinical (99.0%) isolates of S. haemolyticus followed by Type V at 38.0% and 46.9%, respectively. The similar pattern of typing observed indicates the possibility that the clinical isolates of S. haemolyticus could have originated from the commensal strains that had successfully entered the host and caused infections. The antibiotic profile indicates the natural resistance of S. haemolyticus to antibiotics, even among the commensal strains. It also appears that transmission of genetic determinants for antibiotic resistance is common and widespread among all the S. haemolyticus isolates. Commensal strains of S. haemolyticus may thus serve as reservoirs for the transmission of antibiotic resistance and the development of opportunistic strains © 2023 Farhan Haziq Azharollah et al. This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/)
publisher Open Science Publishers LLP Inc.
issn 22313354
language English
format Article
accesstype All Open Access; Gold Open Access
record_format scopus
collection Scopus
_version_ 1812871797606973440